| 1. | Noto, D, K. Takahashi, S. Miyake, M. Yamada. In vitro differentiation of lineage-negative bone marrow cells into microglia-like cells. Eur J Neuroscience 31:1155-63, 2010 |
| 2. | Sakuishi, K, S. Miyake and Yamamura, T.: Role of NK cells and NKT cells in multiple sclerosis. Results Problem Cell Differ 51: 127-147, 20010 pp127-147 |
| 3. | Chang, Y-J, H. Y. Kim, L. A. Albacker, H.-H. Lee, N. Baumgarth, S. Akira, P. Savage, S. Endo, T. Yamamura, J. Maaskant, N. Kitano, A. Singh, A. Bhatt, G. Besra, P. van den Elzen, B. Appelmelk, R. W. Franck, G. Chen, R. DeKruyff, M. Shimamura, P. Illarionov, and D. Umetsu. Influenza A infection in suckling mice expands a population of NKT cells that protects mice as adults from airway hyperreactivity. J. Clin. Invest. 121:57-69, 2010 |
| 4. | Chihara, N, T. Aranami, W. Sato, Y. Miyazaki, S. Miyake, T. Okamoto, M. Ogawa, T. Toda, and T. Yamamura: Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. PNAS 108:3701-3706, 2011 |
| 5. | Miyazaki Y, Miyake S, Chiba A, Lantz O, Yamamura T : Mucosal-associated invariant T cells regulate T helper type 1 response in multiple sclerosis. Int. Immunol. 23(9):529-535, 2011 |
| 6. | Sanvito L, Tomita A, Chihara N, Okamoto T, Ogawa M, Gran B, Aranami T, Yamamura T: Increase of Ki-67+ natural killer cells in multiple sclerosis patients treated with interferon- and interferon-b combined with low-dose oral steroids. J. Neuroimmunol. 236: 111-117, 2011 |
| 7. | Chiba A, Tajima R, Tomi C, Miyazaki Y, Yamamura T, Miyake S.: Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis. Arthritis Rheum. 64: 153-161, 2012 |
| 8. | Ichikawa D, Mizuno M, Yamamura T, Miyake S.: Gene related to anergy in lymphocytes (GRAIL) regulates cytoskeletal reorganization through ubiquitination and degradation of Arp2/3-5 and coronin 1A. J Biol Chem. 286(50):43465-74, 2011 |
| 9. | Yamamura T: Antibody treatment for multiple sclerosis and neurmyelitis optica. Rinsho Shinkeigaku 51:1156, 2011 |
| 10. | Miyake S: Minds over cytokine. Clin Exp Neuroimmunol 3: 1-5, 2012 |
| 11. | Chiba A, Mizuno M, Tomi C, Tajima R, Alloza I, di Penta A, Yamamura T, Vandenbroeck K, Miyake S: A 4-trifluomethyl analogue of celecoxib inhibits arthritis by suppressing innate immune cell activation. Arthritis Res Ther 14:R9, 2012 |
| 12. | Toba T, Murata K, Futamura J, Nakanishi K, Takahashi B, Takemoto N, Tomino M, Nakatsuka T, Seiichi Imajo S, Goto M, Yamamura T, Miyake S, Annoura H: Synthesis and biological evaluation of truncated α-galactosylceramide derivatives focusing on cytokine induction profile. Bioorg & Medic Chem 20:2850-2859, 2012 |
| 13. | Yamamura T, Miyake S: Editorial. B-cell-directed therapy. Which B cells should be targeted and how? Immunother 4:1-3, 2012 |
| 14. | Sato W, Tomita A, Ichikawa D, Lin Y, Kishida H, Miyake S, Ogawa M, Okamoto T, Murata M, Kuroiwa Y, Aranami T, Yamamura T : CCR2+CCR5+ T cells produce matrix metalloproteinase-p and osteopontin in the pathogenesis of multiple sclerosis. J Immunol 189: 5057-5065, 2012 |
| 15. | Chiba A, Tajima R, Tomi C, Miyazaki Y, Yamamura T, Miyake S. : Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis. Arthritis Rheum 64: 153-161, 2012 |
| 16. | Yamamura T, Miyake S. : B-cell-directed therapy: which B cells should be targeted and how? Immunotherapy 4: 455-457, 2012 |
| 17. | Araki M, Aranami T, Matsuoka T, Nakamura M, Miyake S, Yamamura T. : Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab. Modern Rheumatol published online, (11 July 2012) |
| 18. | Ayzeberg I, Kleiter I, Schroder A, Hellwig K, Chan A, Yamamura T, Gold R. : Interleukin-6 receptor blockade in neuromyelitis optica patients non-responsive to anti-CD20 therapy. JAMA Neurol online first doi:10:1001/jamaneurol.2013.1246 |
| 19. | Raveney BJE, Oki S, Yamamura T. : NR4A2 orchestrates pathogenic Th17 development and initiates autoimmune inflammation. PLOS ONE 8: e56595, 2013 |